Cargando…

Memantine in neurological disorders – schizophrenia and depression

Memantine is used in Alzheimer’s disease treatment as a non-competitive modern-affinity strong voltage-dependent N-methyl-D-aspartate receptor antagonist. The fundamental role of these receptors is to bind glutamate: the main excitatory neurotransmitter in the brain, believed to play a crucial role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czarnecka, Kamila, Chuchmacz, Jakub, Wójtowicz, Przemysław, Szymański, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900025/ https://www.ncbi.nlm.nih.gov/pubmed/33447926 http://dx.doi.org/10.1007/s00109-020-01982-z

Ejemplares similares

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
por: Maciejewska, Karolina, et al.
Publicado: (2021)

Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders
por: Tavakoli-Ardakani, Maria, et al.
Publicado: (2018)

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2020)

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
por: Koola, Maju Mathew
Publicado: (2016)

The Therapeutic Role of Ketogenic Diet in Neurological Disorders
por: Pietrzak, Diana, et al.
Publicado: (2022)

Memantine as an Augmentation Therapy for Anxiety Disorders
por: Schwartz, Thomas L., et al.
Publicado: (2012)

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2017)

Aspartame—True or False? Narrative Review of Safety Analysis of General Use in Products
por: Czarnecka, Kamila, et al.
Publicado: (2021)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Radiolabeled Peptides and Antibodies in Medicine
por: Kręcisz, Paweł, et al.
Publicado: (2020)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)

Memantine in the management of a clinically challenging case of bipolar disorder
por: Agarwal, Vivek, et al.
Publicado: (2009)

Memantine-induced speech problems in two patients with autistic disorder
por: Alaghband-Rad, Javad, et al.
Publicado: (2013)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
por: Muhonen, Leea H, et al.
Publicado: (2008)

Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
por: Lee, Jung Goo, et al.
Publicado: (2012)

New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer’s Disease Research
por: Koźmiński, Przemysław, et al.
Publicado: (2022)

A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life
por: Strzelecki, Dominik, et al.
Publicado: (2013)

Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity
por: Shnayder, Natalia A., et al.
Publicado: (2022)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019)

Memantine can protect against inflammation-based cognitive decline in geriatric depression
por: Van Dyk, Kathleen, et al.
Publicado: (2020)

DEPRESSIVE DISORDERS IN SCHIZOPHRENIA
por: Raju, S.S.
Publicado: (1986)

Efficacy of Memantine in Schizophrenic Patients: A Systematic Review
por: Di Iorio, Giuseppe, et al.
Publicado: (2017)

An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer
por: Raducka, Anita, et al.
Publicado: (2021)

Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model
por: Kłosiński, Karol, et al.
Publicado: (2020)

Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
por: Pae, Chi-Un
Publicado: (2013)

Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
por: Veerman, S. R. T., et al.
Publicado: (2016)

The Effect of Memantine Versus Folic Acid on Cognitive Impairment in Patients with Schizophrenia: A Randomized Clinical Trial
por: Hosseini, Seyed Ahmad, et al.
Publicado: (2023)

Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
por: Maciejewska, Karolina, et al.
Publicado: (2022)

Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention
por: Gęca, Tomasz, et al.
Publicado: (2022)

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Efficacy of Memantine Hydrochloride in Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jp9chgcktugc2jnpq34njt71hf